Literature DB >> 30005779

Role of Operative Management in Stage IV Breast Cancer.

Mediget Teshome1.   

Abstract

The role of operative therapy in stage IV breast cancer continues to evolve with advances in therapy and improvements in survival among this population. Traditionally surgery was performed with palliative intent to alleviate symptoms related to the intact breast primary. Several retrospective studies have challenged this paradigm, demonstrating survival advantage with surgery in de novo metastatic disease. Prospective studies are ongoing and maturing data. A comprehensive approach to local therapy following systemic therapy may be beneficial to achieve improved survival outcome associated with stage IV- no evidence of disease and to decrease local failure in inflammatory breast cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  De novo metastatic breast cancer; Locoregional management of metastatic breast cancer; Surgery for stage IV breast cancer

Mesh:

Year:  2018        PMID: 30005779     DOI: 10.1016/j.suc.2018.03.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Effects of Primary Tumor Resection on Metastatic Breast Cancer Survival and the Predictive Power of Neutrophil: Lymphocyte Ratio on Prognosis.

Authors:  Yaşar Çöpelci; Umut Rıza Gündüz; Bülent Dinç; Nurhan Haluk Belen; Şeyda Gündüz
Journal:  Eur J Breast Health       Date:  2021-10-04

2.  Breast cancer combined with contralateral neck lymph node metastasis: a case report.

Authors:  Xiaoxiao Zhong; Fengjiao Ding; Liyuan Qian; Wei Wu; Yanguang Wen; Boni Ding
Journal:  Diagn Pathol       Date:  2022-07-15       Impact factor: 3.196

3.  Factors Associated with Time to Progression and Overall Survival in Patients with De Novo Metastatic Breast Cancer: A Colombian Cohort.

Authors:  Sandra Esperanza Díaz-Casas; Ximena Briceño-Morales; Leidy Juliana Puerto-Horta; Carlos Lehmann-Mosquera; Martha Cecilia Orozco-Ospino; Luis Hernán Guzmán-AbiSaab; Javier Ángel-Aristizábal; Mauricio García-Mora; Carlos Alfonso Duarte-Torres; Iván Fernando Mariño-Lozano; Clara Briceño-Morales; Ricardo Sánchez-Pedraza
Journal:  Oncologist       Date:  2022-03-04       Impact factor: 5.837

4.  Refusal of cancer-directed surgery in male breast cancer.

Authors:  Shipei Wang; Sichao Chen; Yihui Huang; Di Hu; Wen Zeng; Ling Zhou; Wei Zhou; Danyang Chen; Haifeng Feng; Wei Wei; Chao Zhang; Zeming Liu; Min Wang; Liang Guo
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

5.  The prognostic role of surgery and a nomogram to predict the survival of stage IV breast cancer patients.

Authors:  Xinran Liu; Chengshi Wang; Yu Feng; Chaoyong Shen; Tao He; Zhu Wang; Linjie Ma; Zhenggui Du
Journal:  Gland Surg       Date:  2022-07

6.  Metastatic breast cancer: Who benefits from surgery?

Authors:  Caitlin E Marks; Samantha M Thomas; Oluwadamilola M Fayanju; Gayle DiLalla; Sarah Sammons; E Shelley Hwang; Jennifer K Plichta
Journal:  Am J Surg       Date:  2021-07-22       Impact factor: 2.565

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.